Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2394

1.

Cannabidiol and the Remainder of the Plant Extract Modulate the Effects of Δ9-Tetrahydrocannabinol on Fear Memory Reconsolidation.

Murkar A, Kent P, Cayer C, James J, Durst T, Merali Z.

Front Behav Neurosci. 2019 Aug 1;13:174. doi: 10.3389/fnbeh.2019.00174. eCollection 2019.

2.

Cannabinoids and inflammation: Implications for People Living with HIV.

Costiniuk CT, Jenabian MA.

AIDS. 2019 Aug 12. doi: 10.1097/QAD.0000000000002345. [Epub ahead of print]

PMID:
31408029
3.

Cannabis Use and Cognition in Adults Prescribed Opioids for Persistent Pain.

Wildes M, Bigand TL, Layton ME, Wilson M.

Pain Manag Nurs. 2019 Aug 9. pii: S1524-9042(19)30101-8. doi: 10.1016/j.pmn.2019.06.014. [Epub ahead of print]

PMID:
31405787
4.

The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study.

Mitelpunkt A, Kramer U, Hausman Kedem M, Zilbershot Fink E, Orbach R, Chernuha V, Fattal-Valevski A, Deutsch L, Heffetz D, Sacks H.

Epilepsy Behav. 2019 Aug 5;98(Pt A):233-237. doi: 10.1016/j.yebeh.2019.07.007. [Epub ahead of print]

5.

Bones and Joints: The Effects of Cannabinoids on the Skeleton.

Ehrenkranz J, Levine MA.

J Clin Endocrinol Metab. 2019 Aug 8. pii: jc.2019-00665. doi: 10.1210/jc.2019-00665. [Epub ahead of print]

PMID:
31393556
6.

A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states.

Itin C, Domb AJ, Hoffman A.

Expert Opin Drug Deliv. 2019 Aug 12:1-5. doi: 10.1080/17425247.2019.1653852. [Epub ahead of print]

PMID:
31393180
7.

Application device for THC:CBD oromucosal spray in the management of resistant spasticity: pre-production testing.

Montero-Escribano P, Vila Silván C.

Expert Rev Med Devices. 2019 Aug 8. doi: 10.1080/17434440.2019.1653182. [Epub ahead of print]

PMID:
31393179
8.

Complex Patterns of Cannabinoid Alkyl Side-Chain Inheritance in Cannabis.

Welling MT, Liu L, Raymond CA, Kretzschmar T, Ansari O, King GJ.

Sci Rep. 2019 Aug 6;9(1):11421. doi: 10.1038/s41598-019-47812-2.

9.

Drugs for anxiety disorders.

[No authors listed]

Med Lett Drugs Ther. 2019 Aug 12;61(1578):121-126. No abstract available.

PMID:
31386647
10.

Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms.

Casarett DJ, Beliveau JN, Arbus MS.

J Palliat Med. 2019 Aug 6. doi: 10.1089/jpm.2018.0658. [Epub ahead of print]

PMID:
31386592
11.

Cannabis and Epilepsy.

Doyle A, Harvey J.

J Dual Diagn. 2019 Aug 6:1-8. doi: 10.1080/15504263.2019.1645372. [Epub ahead of print]

PMID:
31385740
12.

Cannabidiol Regulates the Expression of Keratinocyte Proteins Involved in the Inflammation Process through Transcriptional Regulation.

Jastrząb A, Gęgotek A, Skrzydlewska E.

Cells. 2019 Aug 3;8(8). pii: E827. doi: 10.3390/cells8080827.

13.

The impacts of potency, warning messages, and price on preferences for Cannabis flower products.

Shi Y, Cao Y, Shang C, Pacula RL.

Int J Drug Policy. 2019 Aug 2;74:1-10. doi: 10.1016/j.drugpo.2019.07.037. [Epub ahead of print]

PMID:
31382201
14.

Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program.

Gaston TE, Bebin EM, Cutter GR, Ampah SB, Liu Y, Grayson LP, Szaflarski JP; UAB CBD Program.

Epilepsy Behav. 2019 Aug 1;98(Pt A):201-206. doi: 10.1016/j.yebeh.2019.07.008. [Epub ahead of print]

PMID:
31382177
15.

Dose-dependent cannabidiol-induced elevation of intracellular calcium and apoptosis in human articular chondrocytes.

Winklmayr M, Gaisberger M, Kittl M, Fuchs J, Ritter M, Jakab M.

J Orthop Res. 2019 Aug 5. doi: 10.1002/jor.24430. [Epub ahead of print]

PMID:
31378964
16.

Intraperitoneal cannabidiol attenuates neonatal germinal matrix hemorrhage-induced neuroinflamation and perilesional apoptosis.

Abrantes De Lacerda Almeida T, Santos MV, Da Silva Lopes L, Goel G, Leonardo De Freitas R, De Medeiros P, Crippa JA, Machado HR.

Neurol Res. 2019 Aug 5:1-11. doi: 10.1080/01616412.2019.1651487. [Epub ahead of print]

PMID:
31378168
17.

Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies.

Socała K, Wyska E, Szafarz M, Nieoczym D, Wlaź P.

Neuropharmacology. 2019 Aug 1;158:107733. doi: 10.1016/j.neuropharm.2019.107733. [Epub ahead of print]

PMID:
31377197
18.

Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy.

Franco V, Perucca E.

Drugs. 2019 Aug 1. doi: 10.1007/s40265-019-01171-4. [Epub ahead of print] Review.

PMID:
31372958
19.

Erratum: Investigating the Therapeutic Mechanism of Cannabidiol in a Human Induced Pluripotent Stem Cell (iPSC)-Based Model of Dravet Syndrome.

Sun Y, Dolmetsch RE.

Cold Spring Harb Symp Quant Biol. 2019 Aug 1. pii: 038919. doi: 10.1101/sqb.2018.83.038919. [Epub ahead of print] No abstract available.

PMID:
31371458
20.

A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome.

Heussler H, Cohen J, Silove N, Tich N, Bonn-Miller MO, Du W, O'Neill C, Sebree T.

J Neurodev Disord. 2019 Aug 2;11(1):16. doi: 10.1186/s11689-019-9277-x.

Supplemental Content

Loading ...
Support Center